Nieminen P - Search Results

1

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A. Leinonen M, et al. Among authors: nieminen p. J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9. J Natl Cancer Inst. 2009. PMID: 19903804 Clinical Trial.

2

Effect of type of screening laboratory on population-based occurrence of cervical lesions in Finland.

Nieminen P, Hakama M, Tarkkanen J, Anttila A. Nieminen P, et al. Int J Cancer. 2002 Jun 10;99(5):732-6. doi: 10.1002/ijc.10396. Int J Cancer. 2002. PMID: 12115508

3

Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.

Nieminen P, Hakama M, Viikki M, Tarkkanen J, Anttila A. Nieminen P, et al. Int J Cancer. 2003 Jan 20;103(3):422-6. doi: 10.1002/ijc.10839. Int J Cancer. 2003. PMID: 12471627 Clinical Trial.

4

A randomised public-health trial on automation-assisted screening for cervical cancer in Finland: performance with 470,000 invitations.

Nieminen P, Kotaniemi L, Hakama M, Tarkkanen J, Martikainen J, Toivonen T, Ikkala J, Luostarinen T, Anttila A. Nieminen P, et al. Int J Cancer. 2005 Jun 10;115(2):307-11. doi: 10.1002/ijc.20902. Int J Cancer. 2005. PMID: 15688388 Clinical Trial.

5

Alternative technologies in cervical cancer screening: a randomised evaluation trial.

Anttila A, Hakama M, Kotaniemi-Talonen L, Nieminen P. Anttila A, et al. Among authors: nieminen p. BMC Public Health. 2006 Oct 16;6:252. doi: 10.1186/1471-2458-6-252. BMC Public Health. 2006. PMID: 17042938 Free PMC article.

6

Randomized evaluation trial on automation-assisted screening for cervical cancer: results after 777,000 invitations.

Nieminen P, Kotaniemi-Talonen L, Hakama M, Tarkkanen J, Martikainen J, Toivonen T, Ikkala J, Anttila A. Nieminen P, et al. J Med Screen. 2007;14(1):23-8. doi: 10.1258/096914107780154468. J Med Screen. 2007. PMID: 17362568 Clinical Trial.

7

Cervical cancer screening programme in Finland with an example on implementing alternative screening methods.

Anttila A, Nieminen P. Anttila A, et al. Among authors: nieminen p. Coll Antropol. 2007 Apr;31 Suppl 2:17-22. Coll Antropol. 2007. PMID: 17600933

8

Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3.

Kotaniemi-Talonen L, Anttila A, Malila N, Tarkkanen J, Laurila P, Hakama M, Nieminen P. Kotaniemi-Talonen L, et al. Among authors: nieminen p. Eur J Cancer. 2008 Mar;44(4):565-71. doi: 10.1016/j.ejca.2007.12.002. Epub 2008 Jan 8. Eur J Cancer. 2008. PMID: 18248809 Clinical Trial.

9

Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland.

Leinonen M, Kotaniemi-Talonen L, Anttila A, Dyba T, Tarkkanen J, Nieminen P. Leinonen M, et al. Among authors: nieminen p. Int J Cancer. 2008 Sep 15;123(6):1344-9. doi: 10.1002/ijc.23670. Int J Cancer. 2008. PMID: 18566992

10

Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening.

Kotaniemi-Talonen L, Malila N, Nieminen P, Anttila A, Tarkkanen J, Laurila P, Hakama M. Kotaniemi-Talonen L, et al. Among authors: nieminen p. Int J Cancer. 2008 Dec 15;123(12):2902-6. doi: 10.1002/ijc.23839. Int J Cancer. 2008. PMID: 18792100 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

562 results

Search Page

Filters